All Ireland Cancer Consortium (AICC2015)

Activity: Participating in or organising an event types › Participation in workshop, seminar, course

Description

Title of talk: MErCuRIC1: A Phase I study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in RASMT and RASWT (with aberrant c-MET) mCRC Patients.
Period12 May 2015
Event typeConference
LocationBelfast, United Kingdom